{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:27:21Z","timestamp":1790108841964,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jinf.2024.106301","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:16:54Z","timestamp":1727716614000},"page":"106301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Occurrence and predictors of laboratory abnormalities during outpatient parenteral antimicrobial therapy \u2013 A multicenter cohort study to inform laboratory test monitoring"],"prefix":"10.1016","volume":"89","author":[{"given":"Hester H.","family":"Stoorvogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje","family":"van Egmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiman F.L.","family":"Wertheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen A.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies E.J.L.","family":"Hulscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8996-7070","authenticated-orcid":false,"given":"Lars","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Kiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Koenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Sprong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan P.","family":"van Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Tromp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3923-1478","authenticated-orcid":false,"given":"Olivier","family":"Richel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier","family":"Akkermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"ten Oever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2024.106301_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024564","article-title":"Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient\u2019s perspective: a qualitative study","volume":"8","author":"Berrevoets","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jinf.2024.106301_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013560","article-title":"Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review","volume":"7","author":"Mitchell","year":"2017","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.jinf.2024.106301_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cmi.2021.12.020","article-title":"Safety of prolonged outpatient courses of intravenous antibiotics: a prospective cohort study","volume":"28","author":"Browning","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2024.106301_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cid\/cix733","article-title":"Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy","volume":"66","author":"Keller","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2024.106301_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jac\/dky474","article-title":"Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy","volume":"74","author":"Underwood","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2024.106301_bib6","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2021.213","article-title":"Experiences in outpatient parenteral antimicrobial therapy (OPAT): barriers and challenges from the front lines","volume":"1","author":"Ng","year":"2021","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106301_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciy867","article-title":"2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2024.106301_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlz026","article-title":"Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK","volume":"1","author":"Chapman","year":"2019","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jinf.2024.106301_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jac\/dkt303","article-title":"Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme","volume":"69","author":"Huck","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2024.106301_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy274","article-title":"Outpatient parenteral therapy for complicated Staphylococcus aureus infections: a snapshot of processes and outcomes in the real world","volume":"5","author":"Townsend","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2024.106301_bib11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2015.04.005","article-title":"Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics","volume":"136","author":"Blumenthal","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106301_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/antibiotics12020330","article-title":"Usefulness of routine laboratory tests for follow up of patients receiving outpatient parenteral antimicrobial therapy run by infectious diseases fellows","volume":"12","author":"Frisby","year":"2023","journal-title":"Antibiotics"},{"issue":"8","key":"10.1016\/j.jinf.2024.106301_bib13","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/jac\/dkv130","article-title":"Comparative outcomes of \u03b2-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches","volume":"70","author":"Lee","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2024.106301_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/ciu301","article-title":"Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting","volume":"59","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2024.106301_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad606","article-title":"Serious adverse events and laboratory monitoring regimens for outpatient parenteral antimicrobial therapy with cefazolin and ceftriaxone","volume":"10","author":"Sunagawa","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2024.106301_bib16","article-title":"Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort","volume":"10","author":"Billmeyer","year":"2023","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2024.106301_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2215\/CJN.02730313","article-title":"Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals","volume":"9","author":"Zeng","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106301_bib18","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2022.313","article-title":"Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: a retrospective cohort study","volume":"2","author":"Kaul","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106301_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14423\/SMJ.0000000000000401","article-title":"Outpatient parenteral antimicrobial therapy for adult orthopedic and neurosurgical infections","volume":"109","author":"Felder","year":"2016","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.jinf.2024.106301_bib20","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.jinf.2024.106301_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ndt\/10.4.579","article-title":"Flucloxacillin-induced acute interstitial nephritis","volume":"10","author":"Bakker","year":"1995","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"10.1016\/j.jinf.2024.106301_bib22","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1111\/bcp.13969","article-title":"Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia","volume":"85","author":"van der Heijden","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jinf.2024.106301_bib23","doi-asserted-by":"crossref","first-page":"g6196","DOI":"10.1136\/bmj.g6196","article-title":"Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study","volume":"349","author":"Fralick","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2024.106301_bib24","unstructured":"U.S. Department of Health and Human Services National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Corrected Version 2.1; 2017. Available from: \u3008https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf\u3009."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324002354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324002354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:02:46Z","timestamp":1733148166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324002354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0163445324002354"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106301","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence and predictors of laboratory abnormalities during outpatient parenteral antimicrobial therapy \u2013 A multicenter cohort study to inform laboratory test monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106301"}}